title: Futuximab
text: # Futuximab
  
  Futuximab (992 DS) (INN) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and also binds to HER1.
  
  This drug was developed by Symphogen.
  
  